Yoshiaki Chinen

Lenalidomide and pomalidomide potently interfere with induction of myeloid‐derived suppressor cells in multiple myeloma

Saeko Kuwahara‐Ota, Yuji Shimura, Christian Steinebach et al. · British Journal of Haematology · 2020 · 39 citations · Full text

Identification of <i>IGHC</i>δ–<i>BACH2</i> fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B‐cell lymphoma/leukemia

Satoru Kobayashi, Tomohiko Taki, Yoshiaki Chinen et al. · Genes Chromosomes and Cancer · 2011 · 35 citations

Mixed-phenotype Acute Leukemia, Genetics, Pathology +17

Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis

Hisao Nagoshi, Junya Kuroda, Tsutomu Kobayashi et al. · International Journal of Hematology · 2013 · 33 citations

Lymphoid Neoplasia, Hematology, Histopathology +8

Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma

Yoshiaki Chinen, Junya Kuroda, Yuji Shimura et al. · Cancer Research · 2014 · 33 citations

Hematological Malignancy, Receptor Tyrosine Kinase, Malignant Blood Disorder +14

Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA

Yoshiaki Chinen, Tomohiko Taki, Kazuhiro Nishida et al. · Oncogene · 2007 · 33 citations

Hematological Malignancy, Radiation Oncology, Fusion Partner +9